RELMADA THERAPEUTICS, INC. — Director's Dealing 2023

Dec 19, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2023-12-15

Reporting Person: GLASSPOOL JOHN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-15	Stock Option (right to buy)	$2.48	A	31522	Acquired	2033-12-15	Common Stock (31522)	Direct

Footnotes

F1: The option vests in 16 equal quarterly installments commencing on March 15, 2024.